Old Mission Capital’s Acceleron Pharma XLRN Stock Holding History

Old Mission Capital’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,682	Closed	-$1.15M	–	1360
2021 Q3	$1.15M	Buy	6,682 +903	+16%	+$118K	0.05%	349
2021 Q2	$725K	Buy	+5,779	New	+$729K	0.02%	529
2020 Q3	–	Sell	-8,023	Closed	-$764K	–	669
2020 Q2	$764K	Buy	+8,023	New	+$773K	0.05%	226

Old Mission Capital's XLRN Position: Q4 2021 in Review

Old Mission Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 6,682 shares — an estimated $1.15M sold.

Old Mission Capital first reported a position in XLRN in Q2 2020 and held it in 3 quarters. The position peaked at $1.15M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Old Mission Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Old Mission Capital sold 6,682 Acceleron Pharma shares in Q4 2021, an estimated $1.15M.
Old Mission Capital first reported a position in Acceleron Pharma in Q2 2020 and held it in 3 quarters.
Old Mission Capital's Acceleron Pharma position peaked at $1.15M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Old Mission Capital's 13F filing for Q4 2021, filed 10 Feb 2022.